Navigation Links
The Hastings Center Report table of contents for September-October 2010
Date:9/9/2010

Essays

Title: The Prospects for Personalized Medicine
Author: Shara Yurkiewicz
Summary: Ten years after the release of a working draft of the human genome, major changes have made their way into medical practice, the marketplace, research, and policy.
Title: Personalized Medicine's Ragged Edge
Author: Leonard M. Fleck
Summary: The phrase "personalized medicine" has a built-in positive spin. But little attention has been given to some challenging issues of justice it raises. Some people will clearly benefit a lot, some people will clearly not benefit at all, and many people will benefit somewhat.

Title: Personalized Cancer Care in an Age of Anxiety
Testing provides a few crystal balls.
Author: Susan Gilbert
Summary: To get an idea of how personalized medicine could reshape patient care in the years ahead, one need only look at how it is beginning to reshape the care of patients with cancer, where it has gained its firmest foothold.

Title: A Patient's Experience
When personalized medicine means less medicine.
Author: Marian Fontana
Summary: All cancer survivors know where they were when they were told they had cancer. I was forty-three years old, exercised five days a week, and ate organic vegetables. How could I have cancer? A tickertape of questions scrolled across my mind.

Title: Wanted: Human Biospecimens
Traditional informed consent doesn't fit this research.
Author: Karen J. Maschke
Summary: Collecting and using tissue, blood, urine, and other human biospecimens for various types of research is not new. But for personalized medicine to realize its potential, researchers will need thousands more of these samples for genetic studieswhich raises a host of ethical questions, some of them new to human subjects research.

Title: Direct-to-Consumer Genetic Tests and the Right to Know
Author: Ronni Sandroff
Summary: Dealing with
'/>"/>

Contact: Michael Turton
turtonm@thehastingscenter.org
845-424-4040 x242
The Hastings Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. The Hastings Center Report table of contents for May/June 2010
2. CPM Resource Centers 19th international conference
3. UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center
4. Trauma center care cost-effective
5. Speed electronic medical record adoption via key medical centers, says Management Science
6. Penns Positive Psychology Center awards $2.9 million for research
7. UT Southwesterns cancer center earns National Cancer Institute designation
8. Mayo Clinic Center for Innovation to sponsor a collaborative symposium on innovations in health care experience and delivery
9. $9M NIH grant renewal awarded to Case Western Reserve/UHCMC Center for AIDS Research
10. Developmental disabilities center established at Washington University
11. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – is set to host its annual ... West Orange, NJ on June 1, 2015. Since 2010, ... programs through LRF. , This year, the Lymphoma Research ...
(Date:5/4/2015)... The opportunity for children to dream of ... motivating forces behind The Fairy Godmother Next Door, a new ... L. Stark. , The inspiration for the enchanting story of ... from Stark’s desire to be a fairy godmother. , “My ... to my neighbors’ children since they were born. We discuss ...
(Date:5/4/2015)... 2015 In May of 2010, after two ... life. In the wake of this tragedy, Ty’s parents Kirk ... that exposes the grim reality of bullying and its devastating ... Kirk and Laura to share their story and offer education ... to another family — a mission that took the Smalley ...
(Date:5/4/2015)... May 04, 2015 The U.S. healthcare ... boomers join the ranks of senior citizens (1) and ... an already over-burdened healthcare system. Additionally, as older healthcare ... replace them. Per the U.S. Census Bureau, the number ... increase 75% by 2050 while those 25 to 54 ...
(Date:5/4/2015)... Ticket Down is a reputable source for ... . While the World Cup is the most known ... years, the International Champions Cup is one of the biggest ... attendance record for soccer in the United States set when ... the University of Michigan. This year, the defending champion Manchester ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4
... to Demonstrate Single-Agent Activity, - 38% Response Rate, 43% Disease Control ... Refractory Hodgkin Lymphoma ... in 110mg Cohort, ... Including an 18% Response Rate in Evaluable Diffuse Large B- cell ...
... that has saved more than 100,000 lives, now is saving ... disease progression with long term use in adults with chronic ... continues to show how much Gleevec has completely changed the ... Druker, M.D., director of the OHSU Cancer Institute. , ...
... ATLANTA, GA, December 8, 2007 -- Results from two ... with bortezomib provide preliminary anti-tumor activity in patients with ... study showed that 10 of 21 (48 percent) evaluable ... ZOLINZA and bortezomib combination treatment. Data from a ...
... 8, 2007 There is a clear link between GABA ... that inhibits neurons in the brain and ... the American College of Neuropsychopharmacology (ACNP) annual meeting. Researchers ... a finding which could potentially help curb the pleasurable ...
... Boca Raton, FL, December 8, 2007 Bipolar disorder, ... the circadian system the bodys internal clock ... irregularities in the circadian system that can trigger key ... today at the American College of Neuropsychopharmacology (ACNP) annual ...
... Dec. 7 On the heels of today,s,Human ... immigrant,detainees, AIDS Healthcare Foundation (AHF) today criticized the ... disregard for the,health and well-being of people living ... Indifference: HIV/AIDS Services for Immigrants,Detained by the U.S.," ...
Cached Medicine News:Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 2Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 3Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 4Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 5Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 6Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 7Health News:Gleevec, the targeted cancer pill, delivers more good news to patients 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 3Health News:Study suggests nicotine addiction might be controlled by influencing brain mechanisms 2Health News:Studies find stable sleep patterns and regular routines may improve outcomes in bipolar disorder 2Health News:Studies find stable sleep patterns and regular routines may improve outcomes in bipolar disorder 3Health News:Denial of Care for HIV+ Detainees 'Unacceptable,' Says AHF 2
(Date:5/4/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... comprehensive overview of the company,s corporate responsibility efforts. ... approach to corporate responsibility by increasingly leveraging its ... have greater, more sustainable impact. The ... thorough look at the company,s progress on numerous ...
(Date:5/4/2015)... NASHVILLE, Tenn. , May 4, 2015  Verus ... after its acquisition of CPAP Care Club in 2012.  ... CPAP business within the durable medical equipment (DME) industry ... apnea patients for their CPAP supply needs and processes ... we bought this company three years ago, the systems ...
(Date:5/4/2015)... , May 4, 2015 CytoSorbents ... company commercializing its CytoSorb® extracorporeal cytokine adsorber to ... countries worldwide, will report Q1 2015 financial results ... 2015.  CytoSorbents, management will host ... will recount both operational and financial progress during ...
Breaking Medicine Technology:Lilly Releases Corporate Responsibility, Global Health Reports 2Lilly Releases Corporate Responsibility, Global Health Reports 3Lilly Releases Corporate Responsibility, Global Health Reports 4Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3
... for maintaining a healthy immune systemPURCHASE, N.Y., Jan. 6 ... Cancer (60(5), 643-651) by researchers at Kansai Medical ... Hexose Correlated Compound) enhances immune function by increasing the ... part of the immune system responsible for presenting foreign ...
... 6 Pacira Pharmaceuticals, Inc., an,acute care specialty ... in two pivotal Phase III SIMPLE trials to ... administration of EXPAREL(TM),(DepoBupivacaine) for prolonged postoperative analgesia. , ... in hemorrhoidectomy and in total knee,arthroplasty (TKA) are ...
Cached Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3
... Graham-Field has been developing ... than 58 years. Our medical-surgical ... reputation for innovation, quality and ... brands include the Labtron® line ...
... Vibrating Mesh Technology to efficiently deliver ... Asthma, COPD or other respiratory conditions. ... and handy carrying case that is ... Powerful delivery comparable to table-top compressor ...
... deliver particulate humidity in the 3 to ... patients. For your convenience, Thera-Mist® nebulizers may ... sterile water., ,The P30000N, for normal ... with a total flow range of 68-24 ...
... as well as humidification, try Flo-Mist™., ... volume, continuous medication nebulizer (CMN), engineered to ... 200 ml reservoir and jet flow design ... nebulized medication delivery at 25 ml/hr. Particles ...
Medicine Products: